Bacterial Vaginosis Drugs

The latest market report published by Credence Research, Inc. “Bacterial Vaginosis Drugs Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025,” the global bacterial vaginosis drugs market is set to grow at a CAGR of 2.9 % from 2017 to 2025.

Market Insights

The microflora imbalance due to the substitution of hydrogen peroxide producing Lactobacilli sp., with that of harmful bacterial species such as G.vaginalis, Mycoplasma and Ureaplasma causes bacterial vaginosis. It is very important to understand that few women experience the infection for a longer period of time and some for a transient period. The whiff test is used for the diagnosis of bacterial vaginosis which is asymptomatic in most cases. The recent approval of SPL7013 an astrodimer sodium is used for the treatment of recurring bacterial vaginosis due to is antiviral properties. Secnidazole (Solosec) is set to replace metronidazole as a single dose to be taken once in day orally. The granules are sprinkled over yogurt, pudding or apple sauce and consumed within 30 minutes without chewing the granules.

Browse the full report Bacterial Vaginosis Drugs Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/bacterial-vaginosis-drugs-market

Metronidazole and clindamycin are prescribed by physicians globally as the first line of treatment in bacterial vaginosis. The dominance of antibiotics is backed by a reason that the generic antibiotics available are both oral and topical formulations at affordable prices. Normal pH retention gels will highlight quick acceptance owing to its nontoxicity and immediate symptomatic relief.

Dominance of North America in the bacterial vaginosis drugs market has been related to the rising prevalence of bacterial vaginosis in non-white women due to unsafe sex, and poor lifestyle such as binge drinking and incessant cigarette smoking. The presence of established generic market for antibiotic drugs, and lack of knowledge regarding self hygiene will project an impressive growth for bacterial drugs market in Asia Pacific.

The bacterial vaginosis drugs market includes major players such as Pfizer, Inc., Bayer AG, Mylan N.V., Novartis AG, Abbott Laboratories, Inc., Symbiomix Therapeutics, Sun Pharmaceutical Industries Ltd., Sanofi Aventis, Starpharma Holdings Limited and Perrigo Company Plc.

Key Market Movements:

  • Rising prevalence of bacterial vaginosis in women from 18-44 years age group
  • In the near future product pipeline will address problems such as antibiotic resistance and recurrence of bacterial vaginosis
  • Recently FDA approved drug formulations such as Solosec and VivaGel that will drive the bacterial vaginosis drugs market

Market Segment by Manufacturers

  • Pfizer
  • Mylan
  • Lupin Pharmaceuticals
  • Prasco
  • West-Ward
  • Teva
  • Perrigo
  • Edenvridge

Market Segment by Type

  • Metronidazole
  • Tinidazole
  • Clindamycin
  • Other

Market Segment by Applications

  • Hospital
  • Drug Store
  • Other

Bacterial vaginosis (BV) is a disease of the vagina caused by excessive growth of bacteria.Common symptoms include increased vaginal discharge that often smells like fish.The discharge is usually white or gray in color.Burning with urination may occur.Itching is uncommon.Occasionally, there may be no symptoms.Having BV approximately doubles the risk of infection by a number of other sexually transmitted infections, including HIV/AIDS.It also increases the risk of early delivery among pregnant women.

BV is caused by an imbalance of the naturally occurring bacteria in the vagina.There is a change in the most common type of bacteria and a hundred to thousandfold increase in total numbers of bacteria present.Typically, bacteria other than Lactobacilli become more common.Risk factors include douching, new or multiple sex partners, antibiotics, and using an intrauterine device, among others.However, it is not considered a sexually transmitted infection.Diagnosis is suspected based on the symptoms, and may be verified by testing the vaginal discharge and finding a higher than normal vaginal pH, and large numbers of bacteria.BV is often confused with a vaginal yeast infection or infection with Trichomonas

Source- Wikipedia

LEAVE A REPLY

Please enter your comment!
Please enter your name here